{
  "response": {
    "status": 200
  },
  "symbol": {
    "id": 4559,
    "symbol": "BMY",
    "title": "Bristol-Myers Squibb Company",
    "aliases": [],
    "is_following": false,
    "watchlist_count": 14567
  },
  "cursor": {
    "more": true,
    "since": 248767135,
    "max": 248589935
  },
  "messages": [
    {
      "id": 248767135,
      "body": "$BMY where\u2019s Kermit the frogger?",
      "created_at": "2020-10-07T16:00:04Z",
      "user": {
        "id": 2161633,
        "username": "JGNYC",
        "name": "John G",
        "avatar_url": "https://avatars.stocktwits.com/production/2161633/thumb-1579008956.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2161633/thumb-1579008956.png",
        "join_date": "2019-06-26",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 32,
        "following": 47,
        "ideas": 1940,
        "watchlist_stocks_count": 152,
        "like_count": 1724,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248756757,
      "body": "$BMY buy back to 59 where I sold it March 17 as covid broke out bough it at 55 - bought Merck n did super",
      "created_at": "2020-10-07T15:31:01Z",
      "user": {
        "id": 548837,
        "username": "beefree",
        "name": "robert freed",
        "avatar_url": "https://avatars.stocktwits.com/production/548837/thumb-1519685676.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/548837/thumb-1519685676.png",
        "join_date": "2015-07-13",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 116,
        "following": 60,
        "ideas": 13402,
        "watchlist_stocks_count": 12,
        "like_count": 3022,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248753151,
      "body": "$BMY &amp; TGTX &gt;&gt;&gt;&gt; Accumulation Mode. Strong Buys / Strong Holds.",
      "created_at": "2020-10-07T15:21:12Z",
      "user": {
        "id": 431019,
        "username": "ern1in",
        "name": "Ernest Bosillio",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2014-12-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 209,
        "following": 81,
        "ideas": 25644,
        "watchlist_stocks_count": 51,
        "like_count": 37889,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248751991,
      "body": "$BMY Loaded up yesterday. First time holder of this. Lets go!",
      "created_at": "2020-10-07T15:18:11Z",
      "user": {
        "id": 522426,
        "username": "MarioDuNZCruiser",
        "name": "Mario",
        "avatar_url": "https://avatars.stocktwits.com/production/522426/thumb-1484352715.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/522426/thumb-1484352715.png",
        "join_date": "2015-05-22",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 9,
        "following": 36,
        "ideas": 1215,
        "watchlist_stocks_count": 17,
        "like_count": 2971,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "conversation": {
        "parent_message_id": 248751991,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "likes": {
        "total": 1,
        "user_ids": [
          3355474
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248748439,
      "body": "$BMY man this is due a massive break out, it\u2019s been a long time coming but it\u2019s in the water now.",
      "created_at": "2020-10-07T15:08:30Z",
      "user": {
        "id": 1998399,
        "username": "John89m",
        "name": "John",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2019-04-09",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 14,
        "following": 8,
        "ideas": 1812,
        "watchlist_stocks_count": 9,
        "like_count": 194,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          522426
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248740935,
      "body": "$BMY what mountain is this growing?LOL",
      "created_at": "2020-10-07T14:49:23Z",
      "user": {
        "id": 811677,
        "username": "9d9er",
        "name": "D",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2016-08-04",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 13,
        "following": 61,
        "ideas": 3073,
        "watchlist_stocks_count": 39,
        "like_count": 946,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248736673,
      "body": "$BMY what is this?",
      "created_at": "2020-10-07T14:38:31Z",
      "user": {
        "id": 1439820,
        "username": "KermitDaFrog",
        "name": "Muppet",
        "avatar_url": "https://avatars.stocktwits.com/production/1439820/thumb-1574091965.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1439820/thumb-1574091965.png",
        "join_date": "2018-03-11",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 103,
        "following": 38,
        "ideas": 6186,
        "watchlist_stocks_count": 41,
        "like_count": 3773,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          2161633
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248733911,
      "body": "$BMY if short. Time to cover",
      "created_at": "2020-10-07T14:31:58Z",
      "user": {
        "id": 859121,
        "username": "bobky",
        "name": "bob Tyler",
        "avatar_url": "https://avatars.stocktwits.com/production/859121/thumb-1539637554.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/859121/thumb-1539637554.png",
        "join_date": "2016-10-13",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 183,
        "following": 106,
        "ideas": 18593,
        "watchlist_stocks_count": 51,
        "like_count": 19689,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248719706,
      "body": "$BMY we fall 2x the index yesterday and on good trail data and a big Green Day we can\u2019t even beat the indexes",
      "created_at": "2020-10-07T13:58:27Z",
      "user": {
        "id": 3104752,
        "username": "FakeNewsPolice69",
        "name": "John Doe",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2020-02-18",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 0,
        "following": 0,
        "ideas": 13,
        "watchlist_stocks_count": 1,
        "like_count": 1,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "conversation": {
        "parent_message_id": 248719706,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "likes": {
        "total": 1,
        "user_ids": [
          3914161
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248706235,
      "body": "$BMY NEW ARTICLE : Bristol Myers Shares Up On Positive Data For Lung Cancer Treatment https://www.stck.pro/news/BMY/8291794",
      "created_at": "2020-10-07T13:24:23Z",
      "user": {
        "id": 1555408,
        "username": "STCKPRO",
        "name": "STCK.PRO",
        "avatar_url": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "join_date": "2018-07-24",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 3990,
        "following": 2,
        "ideas": 242347,
        "watchlist_stocks_count": 17,
        "like_count": 52,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5011,
        "title": "STCK.PRO",
        "url": "https://dashboard.stck.pro"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14565
        }
      ],
      "links": [
        {
          "title": "Bristol-Myers Squibb Company (BMY)",
          "url": "https://www.stck.pro/news/BMY/8291794",
          "shortened_url": "https://www.stck.pro/news/BMY/8291794",
          "shortened_expanded_url": "stck.pro/news/BMY",
          "description": "Never miss an important article again, stay on top of your investments and become a better investor today! Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Sync with Stocktwits",
          "image": "https://www.stck.pro/img/imac.png",
          "created_at": "2020-10-07T13:24:26Z",
          "video_url": null,
          "source": {
            "name": "Stck",
            "website": "https://www.stck.pro"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_248706235.jpg",
          "large": "https://charts.stocktwits.com/production/large_248706235.jpg",
          "original": "https://charts.stocktwits.com/production/original_248706235.jpg",
          "url": "https://charts.stocktwits.com/production/original_248706235.jpg"
        },
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": false
      }
    },
    {
      "id": 248693511,
      "body": "$BMY Bristol Myers&#39; ozanimod OK&#39;d in Canada for multiple sclerosis \n\nhttps://newsfilter.io/a/a951f82369fa12913004f1fd196738cf",
      "created_at": "2020-10-07T12:36:16Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7069,
        "following": 16,
        "ideas": 562501,
        "watchlist_stocks_count": 1,
        "like_count": 527,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14565
        }
      ],
      "links": [
        {
          "title": "Bristol Myers' ozanimod OK'd in Canada for multiple sclerosis",
          "url": "https://newsfilter.io/a/a951f82369fa12913004f1fd196738cf",
          "shortened_url": "https://newsfilter.io/a/a951f82369fa12913004f1fd196738cf",
          "shortened_expanded_url": "newsfilter.io/a/a951f82369f...",
          "description": "Health Canada approves Bristol Myers Squibb's Zeposia for the treatment of patients with relapsing remitting multiple sclerosis to decrease the frequency of clinical exacerbations.The FDA approved it in March.",
          "image": "https://newsfilter.io/meta-images/?url=https://storage.googleapis.com/iex/api/logos/BMY.png",
          "created_at": "2020-10-07T12:36:17Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          859121
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248693494,
      "body": "$BMY NEW ARTICLE : Bristol Myers Squibb&#39;s stock gains on new Opdivo data in lung cancer https://www.stck.pro/news/BMY/8288969",
      "created_at": "2020-10-07T12:36:13Z",
      "user": {
        "id": 1555408,
        "username": "STCKPRO",
        "name": "STCK.PRO",
        "avatar_url": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "join_date": "2018-07-24",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 3987,
        "following": 2,
        "ideas": 242238,
        "watchlist_stocks_count": 17,
        "like_count": 52,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5011,
        "title": "STCK.PRO",
        "url": "https://dashboard.stck.pro"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14565
        }
      ],
      "links": [
        {
          "title": "Bristol-Myers Squibb Company (BMY)",
          "url": "https://www.stck.pro/news/BMY/8288969",
          "shortened_url": "https://www.stck.pro/news/BMY/8288969",
          "shortened_expanded_url": "stck.pro/news/BMY",
          "description": "Never miss an important article again, stay on top of your investments and become a better investor today! Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Sync with Stocktwits",
          "image": "https://www.stck.pro/img/imac.png",
          "created_at": "2020-10-07T12:36:16Z",
          "video_url": null,
          "source": {
            "name": "Stck",
            "website": "https://www.stck.pro"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_248693494.jpg",
          "large": "https://charts.stocktwits.com/production/large_248693494.jpg",
          "original": "https://charts.stocktwits.com/production/original_248693494.jpg",
          "url": "https://charts.stocktwits.com/production/original_248693494.jpg"
        },
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": false
      }
    },
    {
      "id": 248689090,
      "body": "$BMY Bristol Myers&#39; Opdivo shows incremental benefit over chemo in lung cancer study \n\nhttps://newsfilter.io/a/e0c3a79e5166d10ac5d849977d9ef85d",
      "created_at": "2020-10-07T12:17:15Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7066,
        "following": 16,
        "ideas": 562501,
        "watchlist_stocks_count": 1,
        "like_count": 527,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14565
        }
      ],
      "links": [
        {
          "title": "Bristol Myers' Opdivo shows incremental benefit over chemo in lung cancer study",
          "url": "https://newsfilter.io/a/e0c3a79e5166d10ac5d849977d9ef85d",
          "shortened_url": "https://newsfilter.io/a/e0c3a79e5166d10ac5d849977d9ef85d",
          "shortened_expanded_url": "newsfilter.io/a/e0c3a79e516...",
          "description": "Bristol Myers Squibb announces the successful outcome of a Phase 3 clinical trial, CheckMate-816, evaluating the combination of Opdivo and chemo administered before surgery in patients with resectable non-small cell lung cancer.The study met one of the primary endpoints, pathological complete response at time of surgery compared to chemo alone.",
          "image": "https://newsfilter.io/meta-images/?url=https://storage.googleapis.com/iex/api/logos/BMY.png",
          "created_at": "2020-10-07T12:17:15Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248688297,
      "body": "The Daily Biotech Pulse: Bristol-Myers Squibb&#39;s Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences\n\n$IBB $XBI $BMY  \n\nhttps://m.benzinga.com/article/17815640",
      "created_at": "2020-10-07T12:13:25Z",
      "user": {
        "id": 962572,
        "username": "topstockalerts",
        "name": "Top Stock Alerts",
        "avatar_url": "https://avatars.stocktwits.com/production/962572/thumb-1506783043.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/962572/thumb-1506783043.png",
        "join_date": "2017-02-19",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 54519,
        "following": 53,
        "ideas": 115588,
        "watchlist_stocks_count": 9,
        "like_count": 2161,
        "plus_tier": "life",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 2213,
          "symbol": "IBB",
          "title": "iShares Nasdaq Biotechnology ETF",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 23305
        },
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14565
        },
        {
          "id": 7791,
          "symbol": "XBI",
          "title": "SPDR S&P Biotech",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 11842
        }
      ],
      "conversation": {
        "parent_message_id": 248688297,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "links": [
        {
          "title": "Actionable Trading Ideas, Real Time News, Financial Insight | Benzinga",
          "url": "https://m.benzinga.com/article/17815640",
          "shortened_url": "https://m.benzinga.com/article/17815640",
          "shortened_expanded_url": "m.benzinga.com/article/1781...",
          "description": "Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals.",
          "image": null,
          "created_at": "2020-10-07T12:13:25Z",
          "video_url": null,
          "source": {
            "name": "Benzinga",
            "website": "https://m.benzinga.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248685250,
      "body": "$BMY   premarket movers :=:\nhttps://youtu.be/kpsi8bsdtTY",
      "created_at": "2020-10-07T11:58:16Z",
      "user": {
        "id": 266242,
        "username": "SmallShare",
        "name": "SmallShare Trading",
        "avatar_url": "https://avatars.stocktwits.com/production/266242/thumb-1516705650.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/266242/thumb-1516705650.png",
        "join_date": "2013-10-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 766,
        "following": 0,
        "ideas": 44725,
        "watchlist_stocks_count": 132,
        "like_count": 700,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14565
        }
      ],
      "links": [
        {
          "title": "Live Streaming stock market gauges and our list of Market Movers!",
          "url": "https://youtu.be/kpsi8bsdtTY",
          "shortened_url": "https://youtu.be/kpsi8bsdtTY",
          "shortened_expanded_url": "youtube.com/watch?v=kpsi8bs...",
          "description": "Our list of market movers and live streaming market charts. music Phatt Package https://www.youtube.com/channel/UCnsnwlEH9NrnHrcIpCSOWbw listen on soundcloud...",
          "image": "https://i.ytimg.com/vi/kpsi8bsdtTY/hqdefault.jpg",
          "created_at": "2020-10-07T11:58:16Z",
          "video_url": "//cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fkpsi8bsdtTY%3Ffeature%3Doembed=YouTube=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Dkpsi8bsdtTY=https%3A%2F%2Fi.ytimg.com%2Fvi%2Fkpsi8bsdtTY%2Fhqdefault.jpg=38dd9af069fe4432a0efe5550d2ea231=text%2Fhtml=youtube",
          "source": {
            "name": "YouTube",
            "website": "https://www.youtube.com/"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248684873,
      "body": "$BMY NEW ARTICLE : Here&#39;s Why Bristol Myers Offered MyoKardia $13.1 Billion https://www.stck.pro/news/BMY/8289481",
      "created_at": "2020-10-07T11:56:05Z",
      "user": {
        "id": 1555408,
        "username": "STCKPRO",
        "name": "STCK.PRO",
        "avatar_url": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "join_date": "2018-07-24",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 3982,
        "following": 2,
        "ideas": 242144,
        "watchlist_stocks_count": 17,
        "like_count": 52,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5011,
        "title": "STCK.PRO",
        "url": "https://dashboard.stck.pro"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14565
        }
      ],
      "links": [
        {
          "title": "Bristol-Myers Squibb Company (BMY)",
          "url": "https://www.stck.pro/news/BMY/8289481",
          "shortened_url": "https://www.stck.pro/news/BMY/8289481",
          "shortened_expanded_url": "stck.pro/news/BMY",
          "description": "Never miss an important article again, stay on top of your investments and become a better investor today! Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Sync with Stocktwits",
          "image": "https://www.stck.pro/img/imac.png",
          "created_at": "2020-10-07T11:56:07Z",
          "video_url": null,
          "source": {
            "name": "Stck",
            "website": "https://www.stck.pro"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_248684873.jpg",
          "large": "https://charts.stocktwits.com/production/large_248684873.jpg",
          "original": "https://charts.stocktwits.com/production/original_248684873.jpg",
          "url": "https://charts.stocktwits.com/production/original_248684873.jpg"
        },
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": false
      }
    },
    {
      "id": 248681296,
      "body": "The Daily Biotech Pulse: Bristol-Myers Squibb&#39;s Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences $IBB $XBI $BMY https://benzinga.com/z/17815640#.X32mzz_a1Iw.twitter",
      "created_at": "2020-10-07T11:31:37Z",
      "user": {
        "id": 7108,
        "username": "Benzinga",
        "name": "Benzinga",
        "avatar_url": "https://avatars.stocktwits.com/production/7108/thumb-1568827739.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/7108/thumb-1568827739.png",
        "join_date": "2009-12-04",
        "official": true,
        "identity": "Official",
        "classification": [
          "suggested",
          "official"
        ],
        "followers": 283921,
        "following": 531,
        "ideas": 117743,
        "watchlist_stocks_count": 7,
        "like_count": 112,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 2213,
          "symbol": "IBB",
          "title": "iShares Nasdaq Biotechnology ETF",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 23305
        },
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        },
        {
          "id": 7791,
          "symbol": "XBI",
          "title": "SPDR S&P Biotech",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 11842
        }
      ],
      "links": [
        {
          "title": "The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences",
          "url": "https://benzinga.com/z/17815640#.X32mzz_a1Iw.twitter",
          "shortened_url": "https://benzinga.com/z/17815640#.X32mzz_a1Iw.twitter",
          "shortened_expanded_url": "benzinga.com/general/biotec...",
          "description": "Here's a roundup of top developments in the biotech space over the last 24 hours. (Biotech Stocks Hitting 52-week Highs Oct. 6) (Biotech Stocks Hitting 52-week Lows Oct.",
          "image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_268.jpg",
          "created_at": "2020-10-07T11:31:38Z",
          "video_url": null,
          "source": {
            "name": "Benzinga",
            "website": "https://www.benzinga.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248680991,
      "body": "$KTOV $BMY https://www.opdivo.com/ \ud83d\ude0e\ud83c\udfaf\u2714\u2764\ud83d\ude80",
      "created_at": "2020-10-07T11:29:18Z",
      "user": {
        "id": 3714203,
        "username": "Murdock_Creative",
        "name": "Murdock Creative Investments",
        "avatar_url": "https://avatars.stocktwits.com/production/3714203/thumb-1593499316.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/3714203/thumb-1593499316.png",
        "join_date": "2020-06-30",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7,
        "following": 5,
        "ideas": 95,
        "watchlist_stocks_count": 6,
        "like_count": 127,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        },
        {
          "id": 12967,
          "symbol": "KTOV",
          "title": "Kitov Pharmaceuticals",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 41875
        }
      ],
      "links": [
        {
          "title": "OPDIVO\u00ae (nivolumab)",
          "url": "https://www.opdivo.com/",
          "shortened_url": "https://www.opdivo.com/",
          "shortened_expanded_url": "opdivo.com/",
          "description": "For questions about BMS medicines during this time, please call 1-800-721-8909. It is not known if OPDIVO is safe and effective in children younger than 18 years of age. OPDIVO (10 mg/mL) and YERVOY (5 mg/mL) are injections for intravenous (IV) use.",
          "image": "https://www.opdivo.com/content/dam/commercial/us/opdivodtc/en/image/indication-kidney.png",
          "created_at": "2020-10-07T11:29:20Z",
          "video_url": null,
          "source": {
            "name": "Opdivo",
            "website": "https://www.opdivo.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_248680991.JPG",
          "large": "https://charts.stocktwits.com/production/large_248680991.JPG",
          "original": "https://charts.stocktwits.com/production/original_248680991.JPG",
          "url": "https://charts.stocktwits.com/production/original_248680991.JPG"
        },
        "sentiment": {
          "basic": "Bullish"
        }
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248680173,
      "body": "$BMY Opdivo (nivolumab) Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate https://www.otcdynamics.com/bmy-opdivo-nivolumab-plus-chemotherapy-shows-statistically-significant-improvement-in-pathologic-complete-response-as-neoadjuvant-treatment-of-resectable-non-small-cell-lung-cancer-in-phase-",
      "created_at": "2020-10-07T11:22:29Z",
      "user": {
        "id": 253206,
        "username": "otcdynamics",
        "name": "otcdynamics",
        "avatar_url": "https://avatars.stocktwits.com/production/253206/thumb-1432182723.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/253206/thumb-1432182723.png",
        "join_date": "2013-08-16",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 324,
        "following": 0,
        "ideas": 45364,
        "watchlist_stocks_count": 0,
        "like_count": 53,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5512,
        "title": "project_n",
        "url": "https://www.otcdynamics.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "links": [
        {
          "title": "$BMY Opdivo (nivolumab) Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate",
          "url": "https://www.otcdynamics.com/bmy-opdivo-nivolumab-plus-chemotherapy-shows-statistically-significant-improvement-in-pathologic-complete-response-as-neoadjuvant-treatment-of-resectable-non-small-cell-lung-cancer-in-phase-",
          "shortened_url": "https://www.otcdynamics.com/bmy-opdivo-nivolumab-plus-chemotherapy-shows-statistically-significant-improvement-in-pathologic-complete-response-as-neoadjuvant-treatment-of-resectable-non-small-cell-lung-cancer-in-phase-",
          "shortened_expanded_url": "otcdynamics.com/bmy-opdivo-...",
          "description": "Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 CheckMate -816 trial met a primary endpoint of pathologic complete response (pCR) in resectable non-small cell lung cancer (NSCLC). In the trial, significantly more patients treated with Opdivo (nivolumab) plus chemotherapy before surgery showed no evidence of cancer cells in their resected tissue compared to those treated with chemotherapy alone.",
          "image": null,
          "created_at": "2020-10-07T11:22:30Z",
          "video_url": null,
          "source": {
            "name": "Otcdynamics",
            "website": "https://www.otcdynamics.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": false
      }
    },
    {
      "id": 248680091,
      "body": "$BMY The IRMI-FMT Trial - NCT04577729 \n\nhttps://newsfilter.io/a/2c0f6b459bb96bf5f93b8f520474d084",
      "created_at": "2020-10-07T11:21:45Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7062,
        "following": 16,
        "ideas": 562348,
        "watchlist_stocks_count": 1,
        "like_count": 527,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "links": [
        {
          "title": "The IRMI-FMT Trial - NCT04577729",
          "url": "https://newsfilter.io/a/2c0f6b459bb96bf5f93b8f520474d084",
          "shortened_url": "https://newsfilter.io/a/2c0f6b459bb96bf5f93b8f520474d084",
          "shortened_expanded_url": "newsfilter.io/a/2c0f6b459bb...",
          "description": "The IRMI-FMT Trial - NCT04577729: Secondary Outcome Measures Tumor response [ Time Frame: 3 months after checkpoint inhibitor therapy following FMT. ] Complete response, partial response and stable di..",
          "image": "https://newsfilter.io/meta-images/?url=https://storage.googleapis.com/iex/api/logos/BMY.png",
          "created_at": "2020-10-07T11:21:45Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248679298,
      "body": "$BMY NEW ARTICLE : Opdivo (nivolumab) Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial https://www.stck.pro/news/BMY/8288725",
      "created_at": "2020-10-07T11:15:05Z",
      "user": {
        "id": 1555408,
        "username": "STCKPRO",
        "name": "STCK.PRO",
        "avatar_url": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "join_date": "2018-07-24",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 3982,
        "following": 2,
        "ideas": 242144,
        "watchlist_stocks_count": 17,
        "like_count": 52,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5011,
        "title": "STCK.PRO",
        "url": "https://dashboard.stck.pro"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "links": [
        {
          "title": "Bristol-Myers Squibb Company (BMY)",
          "url": "https://www.stck.pro/news/BMY/8288725",
          "shortened_url": "https://www.stck.pro/news/BMY/8288725",
          "shortened_expanded_url": "stck.pro/news/BMY",
          "description": "Never miss an important article again, stay on top of your investments and become a better investor today! Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Sync with Stocktwits",
          "image": "https://www.stck.pro/img/imac.png",
          "created_at": "2020-10-07T11:15:07Z",
          "video_url": null,
          "source": {
            "name": "Stck",
            "website": "https://www.stck.pro"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_248679298.jpg",
          "large": "https://charts.stocktwits.com/production/large_248679298.jpg",
          "original": "https://charts.stocktwits.com/production/original_248679298.jpg",
          "url": "https://charts.stocktwits.com/production/original_248679298.jpg"
        },
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": false
      }
    },
    {
      "id": 248678171,
      "body": "Opdivo (nivolumab) Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial http://www.conferencecalltranscripts.org/summary/?id=65642&amp;pr=true $BMY",
      "created_at": "2020-10-07T11:04:26Z",
      "user": {
        "id": 210967,
        "username": "cctranscripts",
        "name": "Conference Call Transcripts",
        "avatar_url": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "join_date": "2013-01-30",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 6217,
        "following": 9,
        "ideas": 2330582,
        "watchlist_stocks_count": 0,
        "like_count": 754,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1130,
        "title": "cctranscripts",
        "url": "http://conferencecalltranscripts.org"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "links": [
        {
          "title": "Conference Call Transcripts",
          "url": "http://www.conferencecalltranscripts.org/summary/?id=65642&pr=true",
          "shortened_url": "http://www.conferencecalltranscripts.org/summary/?id=65642&pr=true",
          "shortened_expanded_url": "conferencecalltranscripts.o...",
          "description": "Get notified next time BMY.US makes a similar move!",
          "image": null,
          "created_at": "2020-10-07T11:04:27Z",
          "video_url": null,
          "source": {
            "name": "Conferencecalltranscripts",
            "website": "http://www.conferencecalltranscripts.org"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": false
      }
    },
    {
      "id": 248678090,
      "body": "$BMY [15s. delayed]: Issued Press Release on October 07, 06:59:00: Opdivo (nivolumab) Plus Chemotherapy Shows Statistically Significant Im https://s.flashalert.me/59MUxI",
      "created_at": "2020-10-07T11:03:46Z",
      "user": {
        "id": 595702,
        "username": "fla",
        "name": "FlashAlert_me",
        "avatar_url": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "join_date": "2015-09-09",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2541,
        "following": 60,
        "ideas": 686164,
        "watchlist_stocks_count": 0,
        "like_count": 4,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 4622,
        "title": "FlashAlert",
        "url": "https://flashalert.me/"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "links": [
        {
          "title": "Flash Alert",
          "url": "https://s.flashalert.me/59MUxI",
          "shortened_url": "https://s.flashalert.me/59MUxI",
          "shortened_expanded_url": "businesswire.com/news/home/...",
          "description": "Real-time alerts about equities, ETFs, cryptocurrencies and more sent to any device",
          "image": null,
          "created_at": "2020-10-07T11:03:46Z",
          "video_url": null,
          "source": {
            "name": "Flashalert",
            "website": "https://flashalert.me"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": false
      }
    },
    {
      "id": 248677559,
      "body": "$BMY Opdivo Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Tr.. \n\nhttps://newsfilter.io/a/29b4310816410514f2be888925e7a4fe",
      "created_at": "2020-10-07T10:59:32Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7061,
        "following": 16,
        "ideas": 562170,
        "watchlist_stocks_count": 1,
        "like_count": 527,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "links": [
        {
          "title": "Opdivo (nivolumab) Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial",
          "url": "https://newsfilter.io/a/29b4310816410514f2be888925e7a4fe",
          "shortened_url": "https://newsfilter.io/a/29b4310816410514f2be888925e7a4fe",
          "shortened_expanded_url": "newsfilter.io/a/29b43108164...",
          "description": "Bristol Myers Squibb announced that the Phase 3 CheckMate -816 trial met a primary endpoint of pathologic complete response in resectable non-small cell lung cancer. In the trial, significantly more patients treated with Opdivo plus chemotherapy before surgery showed no evidence of cancer cells in their resected tissue compared to those treated with chemotherapy alone.",
          "image": "https://newsfilter.io/meta-images/?url=https://storage.googleapis.com/iex/api/logos/BMY.png",
          "created_at": "2020-10-07T10:59:34Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248651282,
      "body": "Compared to an average industry PE Ratio of 15.44, $BMY is valued a bit cheaper. https://www.chartmill.com/stock/analyzer/stock/BMY?view=fundamental-analysis&amp;key=2001b027-9d63-4fea-985c-211d9bf9cff9&amp;utm_source=stocktwits&amp;utm_medium=FA&amp;utm_content=BMY&amp;utm_campaign=social_tracking",
      "created_at": "2020-10-07T03:18:00Z",
      "user": {
        "id": 47688,
        "username": "ChartMill",
        "name": "ChartMill",
        "avatar_url": "https://avatars.stocktwits.com/production/47688/thumb-1363343728.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/47688/thumb-1363343728.png",
        "join_date": "2011-01-26",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 21443,
        "following": 892,
        "ideas": 1063481,
        "watchlist_stocks_count": 20,
        "like_count": 32,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1135,
        "title": "ChartMill",
        "url": "http://www.chartmill.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14567
        }
      ],
      "links": [
        {
          "title": null,
          "url": "https://www.chartmill.com/stock/analyzer/stock/BMY?view=fundamental-analysis&key=2001b027-9d63-4fea-985c-211d9bf9cff9&utm_source=stocktwits&utm_medium=FA&utm_content=BMY&utm_campaign=social_tracking",
          "shortened_url": "https://www.chartmill.com/stock/analyzer/stock/BMY?view=fundamental-analysis&key=2001b027-9d63-4fea-985c-211d9bf9cff9&utm_source=stocktwits&utm_medium=FA&utm_content=BMY&utm_campaign=social_tracking",
          "shortened_expanded_url": "chartmill.com/stock/analyze...",
          "description": null,
          "image": null,
          "created_at": "2020-10-07T03:18:00Z",
          "video_url": null,
          "source": {
            "name": "Chartmill",
            "website": "https://www.chartmill.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": false
      }
    },
    {
      "id": 248620179,
      "body": "$BMY NEW ARTICLE : Jim Cramer reveals a list of stocks worth buying after Trump shut down stimulus talks https://www.stck.pro/news/BMY/8279545",
      "created_at": "2020-10-06T23:43:06Z",
      "user": {
        "id": 1555408,
        "username": "STCKPRO",
        "name": "STCK.PRO",
        "avatar_url": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "join_date": "2018-07-24",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 3980,
        "following": 2,
        "ideas": 242029,
        "watchlist_stocks_count": 17,
        "like_count": 52,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5011,
        "title": "STCK.PRO",
        "url": "https://dashboard.stck.pro"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14562
        }
      ],
      "links": [
        {
          "title": "Bristol-Myers Squibb Company (BMY)",
          "url": "https://www.stck.pro/news/BMY/8279545",
          "shortened_url": "https://www.stck.pro/news/BMY/8279545",
          "shortened_expanded_url": "stck.pro/news/BMY",
          "description": "Never miss an important article again, stay on top of your investments and become a better investor today! Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Sync with Stocktwits",
          "image": "https://www.stck.pro/img/imac.png",
          "created_at": "2020-10-06T23:43:08Z",
          "video_url": null,
          "source": {
            "name": "Stck",
            "website": "https://www.stck.pro"
          }
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          3884537
        ]
      },
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_248620179.jpg",
          "large": "https://charts.stocktwits.com/production/large_248620179.jpg",
          "original": "https://charts.stocktwits.com/production/original_248620179.jpg",
          "url": "https://charts.stocktwits.com/production/original_248620179.jpg"
        },
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": false
      }
    },
    {
      "id": 248606736,
      "body": "$BMY Alexion buyout.\n\nIt&#39;s coming..Enough Said. Buy buy buy..\n\nEV MIKE HAS SPOKEN...\n https://www.google.com/amp/s/seekingalpha.com/amp/article/4377644-biocrysts-bcx9930-alexions-biggest-headache-now",
      "created_at": "2020-10-06T22:31:07Z",
      "user": {
        "id": 2961540,
        "username": "EVMike",
        "name": "Michael",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2019-12-11",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 23,
        "following": 16,
        "ideas": 133,
        "watchlist_stocks_count": 20,
        "like_count": 471,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14563
        }
      ],
      "links": [
        {
          "title": "BioCryst's BCX9930: Alexion's Biggest Headache Now (NASDAQ:BCRX)",
          "url": "https://www.google.com/amp/s/seekingalpha.com/amp/article/4377644-biocrysts-bcx9930-alexions-biggest-headache-now",
          "shortened_url": "https://www.google.com/amp/s/seekingalpha.com/amp/article/4377644-biocrysts-bcx9930-alexions-biggest-headache-now",
          "shortened_expanded_url": "seekingalpha.com/article/43...",
          "description": "On September 30, BioCryst (NASDAQ: BCRX) reported the results of BCX9930's Proof of Concept as an oral treatment for PNH as Monotherapy. The results have been very promising confirming the good expectations that existed. Total of seven patients were in the trial, and data from four treatment na\u00efve patients showed clinical benefit who received more than six weeks of BCX9930 monotherapy dose of 400 mg.",
          "image": "https://static.seekingalpha.com/images/marketing_images/health_medical/isolated_1188036_960_720.png",
          "created_at": "2020-10-06T22:31:09Z",
          "video_url": null,
          "source": {
            "name": "Seeking Alpha",
            "website": "https://seekingalpha.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248605094,
      "body": "$BMY this should be fine either way.. perhaps 60 before the end of the month",
      "created_at": "2020-10-06T22:23:39Z",
      "user": {
        "id": 3668897,
        "username": "talktomenow",
        "name": "Chad",
        "avatar_url": "https://avatars.stocktwits.com/production/3668897/thumb-1592850492.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/3668897/thumb-1592850492.png",
        "join_date": "2020-06-22",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 20,
        "following": 7,
        "ideas": 1480,
        "watchlist_stocks_count": 32,
        "like_count": 295,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14563
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248603502,
      "body": "$BMY We had support and resistance at $59 for a long time.  Of course with S&amp;P down 1.4% BMY goes down 2.47%.  If S&amp;P goes up tomorrow then BMY will still go down. \ud83e\udd21",
      "created_at": "2020-10-06T22:16:19Z",
      "user": {
        "id": 2235245,
        "username": "Tequila1942",
        "name": "Tequila1942",
        "avatar_url": "https://avatars.stocktwits.com/production/2235245/thumb-1587440188.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2235245/thumb-1587440188.png",
        "join_date": "2019-07-31",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 3,
        "following": 0,
        "ideas": 208,
        "watchlist_stocks_count": 0,
        "like_count": 81,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14565
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          3914161
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": true
      }
    },
    {
      "id": 248589935,
      "body": "Your daily News digest for Bristol Myers Squibb Company $BMY https://wsfriend.com/daily/news/BMY/2020-10-06/",
      "created_at": "2020-10-06T21:22:03Z",
      "user": {
        "id": 732840,
        "username": "WallStreetFriend",
        "name": "Wall Street Friend",
        "avatar_url": "https://avatars.stocktwits.com/production/732840/thumb-1577167895.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/732840/thumb-1577167895.png",
        "join_date": "2016-04-17",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 496,
        "following": 39,
        "ideas": 65431,
        "watchlist_stocks_count": 31,
        "like_count": 94,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5142,
        "title": "Programmatic Alerts ",
        "url": "https://wsfriend.com"
      },
      "symbols": [
        {
          "id": 4559,
          "symbol": "BMY",
          "title": "Bristol-Myers Squibb Company",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 14562
        }
      ],
      "links": [
        {
          "title": "BMY Trending News and Daily News Digest for on Oct 06, 2020",
          "url": "https://wsfriend.com/daily/news/BMY/2020-10-06/",
          "shortened_url": "https://wsfriend.com/daily/news/BMY/2020-10-06/",
          "shortened_expanded_url": "wsfriend.com/daily/news/BMY...",
          "description": "BMY Dail News Digest and Top trending news for",
          "image": "https://g.foolcdn.com/editorial/images/594207/biotech-scientists-lab-technicians-getty.jpg",
          "created_at": "2020-10-06T21:22:04Z",
          "video_url": null,
          "source": {
            "name": "Wsfriend",
            "website": "https://wsfriend.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      },
      "filters": {
        "day_counts": 0,
        "official_api": false
      }
    }
  ]
}